- Home
- DCTH vs FINS Comparison
DCTH vs FINS Comparison
Compare DCTH & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- FINS
- Stock Information
- Founded
- DCTH 1988
- FINS 2019
- Country
- DCTH United States
- FINS United States
- Employees
- DCTH N/A
- FINS N/A
- Industry
- DCTH Medical/Dental Instruments
- FINS Finance/Investors Services
- Sector
- DCTH Health Care
- FINS Finance
- Exchange
- DCTH Nasdaq
- FINS Nasdaq
- Market Cap
- DCTH 387.2M
- FINS 323.3M
- IPO Year
- DCTH N/A
- FINS N/A
- Fundamental
- Price
- DCTH $10.91
- FINS $12.84
- Analyst Decision
- DCTH Strong Buy
- FINS
- Analyst Count
- DCTH 4
- FINS 0
- Target Price
- DCTH $21.50
- FINS N/A
- AVG Volume (30 Days)
- DCTH 375.2K
- FINS 78.0K
- Earning Date
- DCTH 11-08-2024
- FINS 01-01-0001
- Dividend Yield
- DCTH N/A
- FINS 9.97%
- EPS Growth
- DCTH N/A
- FINS N/A
- EPS
- DCTH N/A
- FINS N/A
- Revenue
- DCTH $22,644,000.00
- FINS N/A
- Revenue This Year
- DCTH $1,605.13
- FINS N/A
- Revenue Next Year
- DCTH $111.67
- FINS N/A
- P/E Ratio
- DCTH N/A
- FINS N/A
- Revenue Growth
- DCTH 945.91
- FINS N/A
- 52 Week Low
- DCTH $3.43
- FINS $11.61
- 52 Week High
- DCTH $13.30
- FINS $12.57
- Technical
- Relative Strength Index (RSI)
- DCTH 57.95
- FINS 49.61
- Support Level
- DCTH $11.67
- FINS $12.79
- Resistance Level
- DCTH $13.30
- FINS $13.11
- Average True Range (ATR)
- DCTH 0.73
- FINS 0.10
- MACD
- DCTH 0.01
- FINS 0.02
- Stochastic Oscillator
- DCTH 34.60
- FINS 36.84
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.